- Home
- SBT vs VNDA Comparison
SBT vs VNDA Comparison
Compare SBT & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBT
- VNDA
- Stock Information
- Founded
- SBT 1984
- VNDA 2002
- Country
- SBT United States
- VNDA United States
- Employees
- SBT N/A
- VNDA N/A
- Industry
- SBT Savings Institutions
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- SBT Finance
- VNDA Health Care
- Exchange
- SBT Nasdaq
- VNDA Nasdaq
- Market Cap
- SBT 249.0M
- VNDA 257.8M
- IPO Year
- SBT 2017
- VNDA 2006
- Fundamental
- Price
- SBT $4.61
- VNDA $4.43
- Analyst Decision
- SBT
- VNDA Strong Buy
- Analyst Count
- SBT 0
- VNDA 2
- Target Price
- SBT N/A
- VNDA $16.50
- AVG Volume (30 Days)
- SBT 17.2K
- VNDA 649.7K
- Earning Date
- SBT 01-30-2025
- VNDA 02-13-2025
- Dividend Yield
- SBT N/A
- VNDA N/A
- EPS Growth
- SBT N/A
- VNDA N/A
- EPS
- SBT 0.04
- VNDA N/A
- Revenue
- SBT $66,063,000.00
- VNDA $198,772,000.00
- Revenue This Year
- SBT N/A
- VNDA $16.07
- Revenue Next Year
- SBT N/A
- VNDA $24.42
- P/E Ratio
- SBT $115.25
- VNDA N/A
- Revenue Growth
- SBT N/A
- VNDA 3.18
- 52 Week Low
- SBT $4.40
- VNDA $3.71
- 52 Week High
- SBT $5.97
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- SBT 39.41
- VNDA 44.53
- Support Level
- SBT $4.67
- VNDA $4.34
- Resistance Level
- SBT $4.75
- VNDA $4.65
- Average True Range (ATR)
- SBT 0.07
- VNDA 0.21
- MACD
- SBT -0.01
- VNDA -0.01
- Stochastic Oscillator
- SBT 0.00
- VNDA 36.51
About SBT Sterling Bancorp Inc.
Sterling Bancorp Inc is a unitary thrift holding company. Its primary business is the operation of its wholly-owned subsidiary, Sterling Bank, through which it offers a range of loan products to the residential and commercial markets, as well as retail banking services. The products and services offered by the bank include saving and current accounts, demand and term deposits, payment cards, trade finance, fund transfer, treasury and cash management. It provides services such as construction loans, residential real estate, commercial real estate, commercial lines of credit and other consumer loans.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.